Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Atropine in Myopic Children
NCT06265454Phase 2Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of NVK002 in myopia, sponsored by Ain Shams University. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06265454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06265454.